Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Laboratories Offering Investors Expanded Late-Stage Drug Pipeline
Seeking Alpha
Saturday, September 17, 2011 - 4:27pm
tags:
Abbott Laboratories
Santarus: Weighing A Promising Pipeline Against Patent Challenges
Seeking Alpha
Saturday, September 17, 2011 - 4:10pm
tags:
Santarus
Bayer Evenly Poised
Yahoo/Zacks
Saturday, September 17, 2011 - 4:09pm
tags:
Bayer
Abbott Labs (ABT) Showing $15 Billion In Increased Sales Since Last Year; Value Investing In Dividend Paying Companies From The CIO And President Of Harvest Financial Partners
Wall Street Transcript
Saturday, September 17, 2011 - 4:08pm
tags:
Abbott Laboratories
Exelixis' Shares Plunged: What You Need to Know
Motley Fool
Saturday, September 17, 2011 - 2:53pm
tags:
Exelixis, cabozanitib, prostate cancer
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Saturday, September 17, 2011 - 2:52pm
tags:
Arena Pharmaceuticals, Orexigen, Vivus, Qnexa, weight loss, obesity
A Shrinking Obesity Market
Motley Fool
Saturday, September 17, 2011 - 2:51pm
tags:
weight loss, Vivus, Qnexa, Orexigen, Arena Pharmaceuticals
Theravance's Vibativ Gets EU Nod
Yahoo/Zacks
Saturday, September 17, 2011 - 2:49pm
tags:
Theravance, Vibativ, hospital-acquired pneumonia, pneumonia, MRSA
Gilead: Buy on Core Business Strength, Says Goldman
Barron's
Saturday, September 17, 2011 - 2:47pm
tags:
Gilead Sciences
Merck's $500 Million Venture Bet -- Industry's Latest and Largest Attempt to Get Closer to VCs
InVivo
Friday, September 16, 2011 - 12:41pm
tags:
Merck, venture capital, Merck Research Venture Fund
FDA Declines To Clear Pfizer Antidepressant For Menopausal Symptoms
WSJ Online
Friday, September 16, 2011 - 12:23pm
tags:
menopause, antidepressants, FDA, Pfizer, Pristiq
GSK Anti-Nausea Drug Linked to Arrhythmias
Med Page Today
Friday, September 16, 2011 - 12:13pm
tags:
GSK, anti-nauses, arrhythmias, Zofran
[video] The Next Big Thing In Biotech: Sangamo
TheStreet.com
Friday, September 16, 2011 - 12:10pm
tags:
Sangamo BioSciences, HIV
The Dendreon Debate
Seeking Alpha
Friday, September 16, 2011 - 12:08pm
tags:
Dendreon, Provenge, prostate cancer
Teva Pharma to buy $7.5 million stake in Cocrystal Discovery, which studies antiviral drugs
Yahoo/AP
Friday, September 16, 2011 - 12:08pm
tags:
Teva Pharmaceuticals, Cocrystal Discovery, antivirals
Alexion's Soliris Product Tackles Rare Diseases
Seeking Alpha
Friday, September 16, 2011 - 12:07pm
tags:
Alexion, Soliris, aHUS
3 Large-Cap Drugmakers With Negative Correlation To Volatility
Seeking Alpha
Friday, September 16, 2011 - 10:11am
tags:
Merck, Teva Pharmaceuticals, Novartis
Genzyme to ration rare-disease drug Cerezyme again
Bizjournals.com
Friday, September 16, 2011 - 9:27am
tags:
Genzyme, Cerezyme, Gaucher disease
Boehringer, Eli Say Release Two-Year, Phase III Lingaliptin Data
Bloomberg
Friday, September 16, 2011 - 9:26am
tags:
Boehringer, Eli Lilly, lingaliptin, diabetes
Stop Worrying About Pfizer's Breakup
Motley Fool
Friday, September 16, 2011 - 9:25am
tags:
Pfizer, infant formula

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.